Activation of RaIA is critical for Ras-induced tumorigenesis of human cells

被引:280
作者
Lim, KH
Baines, AT
Fiordalisi, JJ
Shipitsin, M
Feig, LA
Cox, AD
Der, CJ
Counter, CM [1 ]
机构
[1] Duke Univ, Ctr Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA
[2] Duke Univ, Ctr Med, Dept Radiat Oncol, Durham, NC 27710 USA
[3] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27599 USA
[5] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA
[6] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA
关键词
D O I
10.1016/j.ccr.2005.04.030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
RaIGEFs were recently shown to be critical for Ras-mediated transformed and tumorigenic growth of human cells. We now show that the oncogenic activity of these proteins is propagated by activation of one RaIGEF substrate, RaIA, but blunted by another closely related substrate, RaIB, and that the oncogenic signaling requires binding of the RaIBP1 and exocyst subunit effector proteins. Knockdown of RaIA expression impeded, if not abolished, the ability of human cancer cells to form tumors. RaIA was also commonly activated in a panel of cell lines from pancreatic cancers, a disease characterized by activation of Ras. Activation of RaIA signaling thus appears to be a critical step in Ras-induced transformation and tumorigenesis of human cells.
引用
收藏
页码:533 / 545
页数:13
相关论文
共 62 条
[1]   RhoB, not RhoA, represses the transcription of the transforming growth factor β type II receptor by a mechanism involving activator protein 1 [J].
Adnane, J ;
Seijo, E ;
Chen, Z ;
Bizouarn, F ;
Leal, M ;
Sebti, SM ;
Muñoz-Antonia, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (10) :8500-8507
[2]   COMPARATIVE-ANALYSIS OF MUTATIONS IN THE P53 AND K-RAS GENES IN PANCREATIC-CANCER [J].
BERROZPE, G ;
SCHAEFFER, J ;
PEINADO, MA ;
REAL, FX ;
PERUCHO, M .
INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (02) :185-191
[3]   β-arrestins regulate a Ral-GDS-Ral effector pathway that mediates cytoskeletal reorganization [J].
Bhattacharya, M ;
Anborgh, PH ;
Babwah, AV ;
Dale, LB ;
Dobransky, T ;
Benovic, JL ;
Feldman, RD ;
Verdi, JM ;
Rylett, RJ ;
Ferguson, SSG .
NATURE CELL BIOLOGY, 2002, 4 (08) :547-555
[4]  
BOS JL, 1989, CANCER RES, V49, P4682
[5]   MECHANISM OF ACTIVATION OF AN N-RAS GENE IN THE HUMAN FIBRO-SARCOMA CELL-LINE HT1080 [J].
BROWN, R ;
MARSHALL, CJ ;
PENNIE, SG ;
HALL, A .
EMBO JOURNAL, 1984, 3 (06) :1321-1326
[6]   Stable suppression of tumorigenicity by virus-mediated RNA interference [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
CANCER CELL, 2002, 2 (03) :243-247
[7]   BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer - Potential therapeutic targets [J].
Calhoun, ES ;
Jones, JB ;
Ashfaq, R ;
Adsay, V ;
Baker, SJ ;
Valentine, V ;
Hempen, PM ;
Hilgers, W ;
Yeo, CJ ;
Hruban, RH ;
Kern, SE .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (04) :1255-1260
[8]  
CANTOR SB, 1995, MOL CELL BIOL, V15, P4578
[9]   RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival [J].
Chien, YC ;
White, MA .
EMBO REPORTS, 2003, 4 (08) :800-806
[10]   CORRELATION OF PATTERNS OF ANCHORAGE-INDEPENDENT GROWTH WITH INVIVO BEHAVIOR OF CELLS FROM A MURINE FIBRO-SARCOMA [J].
CIFONE, MA ;
FIDLER, IJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (02) :1039-1043